CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cansino Biologics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cansino Biologics Inc
Phone: +86 2258213600p:+86 2258213600 TIANJIN, TNJ  300457  China Ticker: 61856185

Business Summary
CANSINO BIOLOGICS INC., formerly Tianjin CanSino Biotechnology Inc., is a China-based company principally engaged in the research and development, manufacture and commercialization of vaccine products for human use. The Company’s core products consist of two vaccine candidates, namely MCV4 candidate and MCV2 candidate. The Company mainly operates its business in the domestic market.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201912/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Chief Executive Officer, General Manager XuefengYu 55 1/13/2009 1/13/2009
Chief Operating Officer, Deputy General Manager, Executive Director Shou BaiChao 56 6/22/2018 5/1/2018
Senior Vice President, Deputy General Manager, Executive Director DongxuQiu 59 1/13/2009 1/13/2009
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 369 (As of 6/30/2019)
Outstanding Shares: 222,649,899 (As of 6/30/2019)
Stock Exchange: HKG
Fax Number: +86 2258213600


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 08, 2019